A Review Of Patient Reported Outcomes (Pros) In Psoriasis According To The Food And Drug Administration (Fda) Pro Guidance Criteria
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2145
https://www.valueinhealthjournal.com/article/S1098-3015(14)04075-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1609
First Page :
A612
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04075-3&doi=10.1016/j.jval.2014.08.2145